ZURAGARD Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Zuragard, and what generic alternatives are available?
Zuragard is a drug marketed by Zurex Pharma and is included in one NDA. There are seven patents protecting this drug.
This drug has sixty-five patent family members in twenty-two countries.
The generic ingredient in ZURAGARD is isopropyl alcohol. There are thirty-one drug master file entries for this compound. Additional details are available on the isopropyl alcohol profile page.
DrugPatentWatch® Generic Entry Outlook for Zuragard
By analyzing the patents and regulatory protections it appears that the earliest date
for generic entry will be May 23, 2028. This may change due to patent challenges or generic licensing.
Indicators of Generic Entry
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ZURAGARD?
- What are the global sales for ZURAGARD?
- What is Average Wholesale Price for ZURAGARD?
Summary for ZURAGARD
International Patents: | 65 |
US Patents: | 7 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 384 |
Clinical Trials: | 1 |
Patent Applications: | 3,146 |
DailyMed Link: | ZURAGARD at DailyMed |

DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for ZURAGARD
Generic Entry Date for ZURAGARD*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
SOLUTION;TOPICAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for ZURAGARD
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Zurex Pharma, Inc. | Phase 3 |
US Patents and Regulatory Information for ZURAGARD
ZURAGARD is protected by seven US patents.
Based on analysis by DrugPatentWatch, the earliest date for a generic version of ZURAGARD is ⤷ Try for Free.
This potential generic entry date is based on patent 8,703,828.
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zurex Pharma | ZURAGARD | isopropyl alcohol | SOLUTION;TOPICAL | 210872-001 | Apr 26, 2019 | OTC | Yes | Yes | 9,629,368 | ⤷ Try for Free | ⤷ Try for Free | ||||
Zurex Pharma | ZURAGARD | isopropyl alcohol | SOLUTION;TOPICAL | 210872-001 | Apr 26, 2019 | OTC | Yes | Yes | 8,703,828 | ⤷ Try for Free | Y | ⤷ Try for Free | |||
Zurex Pharma | ZURAGARD | isopropyl alcohol | SOLUTION;TOPICAL | 210872-001 | Apr 26, 2019 | OTC | Yes | Yes | 8,389,583 | ⤷ Try for Free | ⤷ Try for Free | ||||
Zurex Pharma | ZURAGARD | isopropyl alcohol | SOLUTION;TOPICAL | 210872-001 | Apr 26, 2019 | OTC | Yes | Yes | 9,844,654 | ⤷ Try for Free | Y | ⤷ Try for Free | |||
Zurex Pharma | ZURAGARD | isopropyl alcohol | SOLUTION;TOPICAL | 210872-001 | Apr 26, 2019 | OTC | Yes | Yes | 10,688,291 | ⤷ Try for Free | Y | ⤷ Try for Free | |||
Zurex Pharma | ZURAGARD | isopropyl alcohol | SOLUTION;TOPICAL | 210872-001 | Apr 26, 2019 | OTC | Yes | Yes | 8,226,971 | ⤷ Try for Free | Y | ⤷ Try for Free | |||
Zurex Pharma | ZURAGARD | isopropyl alcohol | SOLUTION;TOPICAL | 210872-001 | Apr 26, 2019 | OTC | Yes | Yes | 9,011,897 | ⤷ Try for Free | Y | ⤷ Try for Free | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ZURAGARD
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Zurex Pharma | ZURAGARD | isopropyl alcohol | SOLUTION;TOPICAL | 210872-001 | Apr 26, 2019 | 8,226,971 | ⤷ Try for Free |
Zurex Pharma | ZURAGARD | isopropyl alcohol | SOLUTION;TOPICAL | 210872-001 | Apr 26, 2019 | 9,011,897 | ⤷ Try for Free |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ZURAGARD
When does loss-of-exclusivity occur for ZURAGARD?
Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:
Australia
Patent: 09249541
Patent: Antimicrobial compositions and methods of use
Estimated Expiration: ⤷ Try for Free
Brazil
Patent: 0913086
Patent: Composições antimicrobianas e métodos de uso
Estimated Expiration: ⤷ Try for Free
Canada
Patent: 24784
Patent: COMPOSITIONS ANTIMICROBIENNES ET LEURS PROCEDES D'UTILISATION (ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE)
Estimated Expiration: ⤷ Try for Free
China
Patent: 2105055
Patent: Antimicrobial compositions and methods of use
Estimated Expiration: ⤷ Try for Free
Patent: 6466319
Patent: 抗微生物组合物和使用方法 (Antimicrobial compositions and methods of use)
Estimated Expiration: ⤷ Try for Free
Denmark
Patent: 93668
Estimated Expiration: ⤷ Try for Free
European Patent Office
Patent: 93668
Patent: COMPOSITIONS ANTIMICROBIENNES ET LEURS PROCÉDÉS D'UTILISATION (ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE)
Estimated Expiration: ⤷ Try for Free
Israel
Patent: 9507
Patent: תכשירים אנטימיקרוביים ושיטות לשימוש בהם (Antimicrobial compositions and methods of use thereof)
Estimated Expiration: ⤷ Try for Free
Japan
Patent: 34848
Estimated Expiration: ⤷ Try for Free
Patent: 11520960
Estimated Expiration: ⤷ Try for Free
Mexico
Patent: 3841
Patent: COMPOSICIONES ANTIMICROBIANAS Y METODOS DE USO. (ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE.)
Estimated Expiration: ⤷ Try for Free
Patent: 10012739
Patent: COMPOSICIONES ANTIMICROBIANAS Y MÉTODOS DE USO. (ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE.)
Estimated Expiration: ⤷ Try for Free
Poland
Patent: 93668
Estimated Expiration: ⤷ Try for Free
Russian Federation
Patent: 19038
Patent: АНТИМИКРОБНЫЕ КОМПОЗИЦИИ И СПОСОБЫ ПРИМЕНЕНИЯ (ANTIMICROBIAL COMPOSITIONS AND METHODS OF USING THEM)
Estimated Expiration: ⤷ Try for Free
Patent: 48456
Patent: АНТИМИКРОБНЫЕ КОМПОЗИЦИИ И СПОСОБЫ ПРИМЕНЕНИЯ (ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE)
Estimated Expiration: ⤷ Try for Free
Patent: 10152555
Patent: АНТИМИКРОБНЫЕ КОМПОЗИЦИИ И СПОСОБЫ ПРИМЕНЕНИЯ
Estimated Expiration: ⤷ Try for Free
Patent: 14111445
Patent: АНТИМИКРОБНЫЕ КОМПОЗИЦИИ И СПОСОБЫ ПРИМЕНЕНИЯ
Estimated Expiration: ⤷ Try for Free
South Africa
Patent: 1008713
Patent: ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE
Estimated Expiration: ⤷ Try for Free
Spain
Patent: 23909
Estimated Expiration: ⤷ Try for Free
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
See the table below for additional patents covering ZURAGARD around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
China | 102105055 | Antimicrobial compositions and methods of use | ⤷ Try for Free |
Russian Federation | 2007133649 | РАСТВОР ЗАМКА КАТЕТОРА, СОДЕРЖАЩИЙ ЦИТРАТ И ПАРАБЕН | ⤷ Try for Free |
Brazil | 112015026482 | aparelho aplicador cutâneo médico | ⤷ Try for Free |
Mexico | 353841 | COMPOSICIONES ANTIMICROBIANAS Y METODOS DE USO. (ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE.) | ⤷ Try for Free |
World Intellectual Property Organization (WIPO) | 2014172200 | ⤷ Try for Free | |
Japan | 5101019 | ⤷ Try for Free | |
China | 101442956 | Catheter lock solution comprising citrate and paraben | ⤷ Try for Free |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ZURAGARD
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1448186 | 2012C/051 | Belgium | ⤷ Try for Free | PRODUCT NAME: MELANGE DE CATECHOLS ISOLES D'UN EXTRAIT DE THE (CAMELLIA SINENSIS (L.) O. KUNTZE) AVEC DU MYRISTATE D'ISOPROPYLE; AUTHORISATION NUMBER AND DATE: BE424383 20120719 |
0289349 | SPC/GB04/007 | United Kingdom | ⤷ Try for Free | PRODUCT NAME: ISOPROPYL(+)-(Z)-7-((1R,2R,3R,5S)-3,5-DIHYDROXY-2-(3-OXODECYL)CYCLOPENTYL)-5-HEPTENOATE; REGISTERED: CH 55634 01 20010329; UK PL00101/0667 20031112 |
1448186 | C300550 | Netherlands | ⤷ Try for Free | PRODUCT NAME: MENGSEL VAN CATECHOLEN GEISOLEERD UIT EEN EXTRACT VAN GROENE THEE, CAMELLIA SINENSIS, L. O. KUNTZE MET ISOPROPYLMYRISTAAT; NATL. REGISTRATION NO/DATE: RVG 110904 20120920; FIRST REGISTRATION: DE 73486.00.00 20090831 |
0364417 | SPC/GB97/014 | United Kingdom | ⤷ Try for Free | PRODUCT NAME: LATANOPROST (I.E. 13,14-DIHYDRO-17-PHENYL-18,19,20-TRINOR-PGF-ALPHA-ISOPROPYLESTER); NAT. REGISTRATION NO/DATE: 00032/0220 19961216; FIRST REGISTRATION: SE 12716 19960718; SPC EXTENSION AUTHORISATION: PL00057/1057-008 20101216 |
2447254 | 2018015 | Norway | ⤷ Try for Free | PRODUCT NAME: 2-4-(N-(5,6-DIFENYLPYRAZIN-2- YL)-N- ISOPROPYLAMINO)BUTYLOKSY-N-; REG. NO/DATE: EU/1/15/1083 20160530 |
1920764 | 2012/033 | Ireland | ⤷ Try for Free | PRODUCT NAME: TRAVOPROST (ALSO CALLED FLUPROSTENOL ISOPROPYL ESTER); NAT REGISTRATION NO/DATE: EU/1/01/199/001-002 20011129; FIRST REGISTRATION NO/DATE: EU/1/01/199/001-002 20011129; PAEDIATRIC INVESTIGATION PLAN: P/0298/2013 PROCEEDINGS UNDER SECTION 37 OF THE PATENTS ACT, 1992 RESTORATION ORDER DATED 12TH JANUARY 2016, WAS MADE RESTORING THE PATENT MENTIONED BELOW S85583 PAUL DOYLE A RE-USABLE BAG SYSTEM RESTORATION ORDERS DATED 16TH FEBRUARY 2016, WERE MADE RESTORING THE PATENTS MENTIONED BELOW S86133 MERVYN GREENE MULTI PURPOSE TANK STAND WITH COMPLEX LOCKING MECHANISM 86119 MPC GREEN LIMITED ANEW BIN |
2203462 | 2014029 | Norway | ⤷ Try for Free | PRODUCT NAME: SOFOSBUVIR. (S)-ISOPROPYL 2-; NAT. REG. NO/DATE: EU/1/13/894 20140116; FIRST REG. NO/DATE: (001-002) 20140117 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Market Dynamics and Financial Trajectory for ZURAGARD
More… ↓